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Abstract 23 
Epidermal homeostasis depends on a balance between stem cell renewal and terminal 24 
differentiation. The transition between the two cell states, termed commitment, is poorly 25 
understood. Here we characterise commitment by integrating transcriptomic and proteomic 26 
data from disaggregated primary human keratinocytes held in suspension to induce 27 
differentiation. Cell detachment induces several protein phosphatases, five of which - DUSP6, 28 
PPTC7, PTPN1, PTPN13 and PPP3CA – promote differentiation by negatively regulating 29 
ERK MAPK and positively regulating AP1 transcription factors. Conversely, DUSP10 30 
expression antagonises commitment. The phosphatases form a dynamic network of transient 31 
positive and negative interactions that change over time, with DUSP6 predominating at 32 
commitment. Boolean network modelling identifies a mandatory switch between two stable 33 
states (stem and differentiated) via an unstable (committed) state. Phosphatase expression is 34 
also spatially regulated in vivo and in vitro. We conclude that an auto-regulatory phosphatase 35 
network maintains epidermal homeostasis by controlling the onset and duration of 36 
commitment. 37 
 38 
Introduction 39 
Commitment is a transient state during which a cell becomes restricted to a particular 40 
differentiated fate. Under physiological conditions commitment is typically irreversible and 41 
involves selecting one differentiation pathway at the expense of others (Nimmo et al. 2015). 42 
While commitment is a well-defined concept in developmental biology, it is still poorly 43 
understood in the context of adult tissues
 
(Simons & Clevers 2011; Semrau & van 44 
Oudenaarden 2015; Nimmo et al. 2015). This is because end-point analysis fail to capture 45 
dynamic changes in cell state, and rapid cell state transitions can depend on post-translational 46 
events, such as protein phosphorylation and dephosphorylation (Avraham & Yarden 2011).  47 
 48 
We set out to examine commitment in human interfollicular epidermis, which is a multi-49 
layered epithelium formed by keratinocytes and comprises the outer covering of the skin
 
50 
(Watt 2014). The stem cell compartment lies in the basal layer, attached to an underlying 51 
basement membrane. Cells that leave the basal layer undergo a process of terminal 52 
differentiation as they move through the suprabasal layers. In the final stage of terminal 53 
differentiation the cell nucleus and cytoplasmic organelles are lost and cells assemble an 54 
insoluble barrier, called the cornified envelope, which is formed of transglutaminase cross-55 
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linked proteins and lipids
 
(Watt 2014). We have previously shown that keratinocytes can 56 
commit to terminal differentiation at any phase of the cell cycle, and upon commitment they 57 
are refractory to extracellular matrix-mediated inhibition of differentiation
 
(Adams & Watt 58 
1989).  59 
 60 
Although there are currently no markers of epidermal commitment, we have previously used 61 
suspension-induced differentiation of disaggregated human keratinocytes in methylcellulose-62 
containing medium
 
(Adams & Watt 1989) to define its timing. Here we use this simple 63 
experimental model to identify markers of commitment and discover why it is a transient 64 
state. 65 
 66 
Results 67 
Dynamic expression of protein phosphatases during suspension-induced differentiation 68 
Since keratinocytes increase in size as they differentiate
 
(Adams & Watt 1989), we enriched 69 
for undifferentiated cells by filtration prior to placing them in suspension for up to 12h (Fig. 70 
1a). By determining when cells recovered from suspension could no longer resume clonal 71 
growth on replating (Fig.1b; Fig.1-Figure Supplement 1a), we confirmed that there is a 72 
marked drop in colony forming ability between 4 and 8 hours. This correlates with an increase 73 
in the proportion of cells expressing the terminal differentiation markers involucrin (IVL) and 74 
transglutaminase 1 (TGM1) (Fig.1c, d; Fig.1-Figure Supplement 1b) and downregulation of 75 
genes that are expressed in the basal layer of the epidermis, including integrin α6 (ITGα6) 76 
and TP63 (Fig.1d) and the stem cell markers DLL1 and Lrig1 (Tan et al. 2013; Fig.1-Figure 77 
Supplement 1c). As expected, Ki67 expression was also reduced in suspension, reflecting the 78 
drop in proliferation upon differentiation (Fig.1-Figure Supplement 1c).  79 
 80 
To define commitment at the molecular level we next collected keratinocytes after 4, 8 and 81 
12h in suspension and performed genome-wide transcriptomics, using Illumina-based 82 
microarrays, and proteome-wide peptide analysis, by SILAC-Mass-Spectrometry (MS) 83 
(Fig.1e, f; Fig.1-Figure Supplement 1d-g; Fig.1-Table Supplement 1, 2). Keratinocytes 84 
collected immediately after trypsinization served as the 0h control. When comparing the 85 
starting cell population (0h) with cells suspended for 4, 8 or 12h, t-SNE plots of differentially 86 
expressed genes (Fig.1e) and unsupervised hierarchical clustering of genes and proteins 87 
(Fig.1f; Fig.1-Figure Supplement 1d) indicated that the 4h samples clustered separately from 88 
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the 8 and 12h samples. GO term enrichment analysis of differentially expressed transcripts or 89 
proteins showed enrichment of terms associated with epidermal differentiation at 8h and 12h 90 
(Fig.1-Figure Supplement 1e, g)
 
(Sen et al. 2010; Mulder et al. 2012), which is consistent with 91 
the drop in clonogenicity seen at these time points. 92 
 93 
When we compared the significantly differentially expressed proteins (p-value <0.05) that 94 
changed ≥2 fold at one or more time points with their corresponding transcripts (Fig.1g-i), 95 
there was a moderately positive correlation at 8h and 12 h (Pearson correlations of 0.51 and 96 
0.68, respectively), consistent with the correlation between bulk mRNA and protein levels 97 
seen in previous studies of mammalian cells
 
(Schwanhäusser et al. 2011; Ly et al. 2014). 98 
However, at 4h transcripts and proteins were only weakly correlated (Pearson correlation 99 
0.19, Fig.1g). 100 
 101 
The poor correlation between protein and transcript levels at 4h suggested a potential role for 102 
post-transcriptional mechanisms in regulating commitment. To investigate this we performed 103 
unbiased SILAC-MS based phospho-proteomic analysis. SILAC-labelled peptides isolated 104 
from cells at 0, 4 and 8h time points were enriched for phosphopeptides using HILIC pre-105 
fractionation and titanium dioxide affinity chromatography (Fig.1-Table Supplement 3). Over 106 
3,500 high confidence phosphorylation sites were identified with an Andromeda search score 107 
>= 30 and quantified at both the 4 and 8h time points. At 4h approximately two thirds of the 108 
changes involved dephosphorylation (Fig.1j) but these dephosphorylation events could not be 109 
attributed to decreases in protein abundance, as shown by the discordance between total 110 
protein abundance and changes in protein phosphorylation (Fig.1k). 111 
 112 
We next identified protein phosphatases that were differentially expressed between 0 and 4h. 113 
We intersected the proteomic and genomic datasets, revealing 47 differentially expressed 114 
phosphatases, 22 of which were upregulated (Fig. 2a). Interrogation of published datasets 115 
revealed that these phosphatases were also dynamically expressed during calcium-induced 116 
stratification of human keratinocytes
 
(Hopkin et al. 2012) and differentiation of reconstituted 117 
human epidermis
 
(Lopez-Pajares et al. 2015) (Fig.2-Figure Supplement 2 a, b). 118 
 119 
Identification of protein phosphatases that regulate commitment 120 
To examine the effects on keratinocyte self-renewal of knocking down each of the 22 121 
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phosphatases identified in the screen, we transfected primary human keratinocytes with 122 
SMART pool siRNAs and measured colony formation in culture (Fig.2b; Fig.2-Figure 123 
Supplement 3a). Live-cell imaging was used to monitor cell growth for three days post-124 
transfection (Fig.2-Figure Supplement 3b). Knocking down seven of the phosphatases 125 
significantly increased clonal growth (Fig.2b), with five phosphatases – DUSP6, PPTC7, 126 
PTPN1, PTPN13 and PPP3CA - having the most pronounced effect (p-value <0.001). 127 
Silencing of these five phosphatases also increased colony size and delayed the loss of colony 128 
forming ability in suspension (Fig.2c, d; Fig.2-Figure Supplement 3c-d). Consistent with 129 
these findings, phosphatase knockdown delayed the decline in TP63 and increase in TGM1 130 
levels during suspension-induced differentiation (Fig.2e, f; Fig.2-Table Supplement 4). 131 
Knocking down each phosphatase did not have a major effect on the growth rate of 132 
keratinocytes and live-cell imaging did not reveal any apoptosis (Fig.2-Figure Supplement 133 
3e). Cumulatively, the effects on keratinocyte self-renewal and differentiation suggest that 134 
DUSP6, PPTC7, PTPN1, PTPN13 and PPP3CA are pro-commitment protein phosphatases. 135 
 136 
The effects of knocking down DUSP10 at 0h differed from those of the other 5 phosphatases. 137 
DUSP10 knockdown significantly reduced clonogenicity (p-value<0.001; Fig. 2b; Fig.2-138 
Figure Supplement 3a) and, in contrast to the other phosphatases, decreased the growth rate of 139 
keratinocytes (Fig.2-Figure Supplement 3b, e). In addition, whereas expression of DUSP6, 140 
PPTC7, PTPN1, PTPN13 and PPP3CA declined by 8h in suspension, DUSP10 expression 141 
remained high (Fig. 2a). Taken together, their effects on keratinocyte self-renewal and 142 
differentiation suggest that all six are commitment-associated protein phosphatases, with 143 
DUSP10 differing from the other phosphatases in potentially antagonising commitment. 144 
 145 
To examine the effect of knocking down the pro-commitment phosphatases on the ability of 146 
keratinocytes to reconstitute a multi-layered epithelium, we seeded cells on de-epidermised 147 
human dermis and cultured them at the air-medium interface for three weeks (Fig.2g; Fig.2-148 
Figure Supplement 3f, g). Knockdown of DUSP6, PTPN1, PPP3CA and PTPN13 did not 149 
prevent cells from undergoing terminal differentiation, as evidenced by suprabasal expression 150 
of involucrin and accumulation of cornified cells (Fig.2g; Fig.2-Figure Supplement 3f). 151 
However, the number of TP63-positive cells was increased, whether measured as a proportion 152 
of the total number of cells (Fig.2g) or per length of basement membrane (Fig.2-Figure 153 
Supplement 3g). Knockdown of DUSP6, PTPN1 or PPP3CA increased epidermal thickness 154 
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without increasing the proportion of proliferative, Ki67-positive cells (Fig.2g; Fig.2-Figure 155 
Supplement 3g). Conversely, PTPN13 knockdown led to an increase in the percentage of 156 
Ki67-positive cells and a slight reduction in epidermal thickness (Fig.2g), which could reflect 157 
an increased rate of transit through the epidermal layers. In addition, Ki67 and TP63-positive 158 
cells were no longer confined to the basal cell layer of epidermis reconstituted following 159 
phosphatase knockdown, but were also present throughout the viable suprabasal layers.  160 
 161 
To complement our studies with siRNAs, which achieve transient knockdown, we performed 162 
stable knockdown of the pro-commitment phosphatases with shRNA lentiviral vectors (two 163 
different shRNAs per target; Fig.2-Figure Supplement 4a) and performed epidermal 164 
reconstitution experiments (Fig.2-Figure Supplement 4b, c). We also developed a tool for 165 
automated, unbiased measurements of epidermal thickness (Fig.2-Figure Supplement 5, 166 
Source Code 1). No apoptotic cells were observed in reconstituted epidermis, as evaluated by 167 
lack of Caspase 3 labelling. Consistent with the effects of siRNA-mediated knockdown, 168 
stable knockdown of DUSP6, PPTC7, PTPN1 and PPP3CA increased epidermal thickness, 169 
whereas PTPN13 knockdown did not (Fig.2-Figure Supplement 4b, c). We also confirmed 170 
expansion of the TP63+ compartment (Fig.2-Figure Supplement 4d). Virtually all Ki67+ cells 171 
co-expressed TP63 (Fig.2-Figure Supplement 4d, e). Furthermore, many suprabasal cells co-172 
expressed TP63 and IVL (Fig.2-Figure Supplement 4f). Thus on both transient and stable 173 
knockdown the transition from the stem to the differentiated cell compartment was disturbed 174 
(Fig.2-Figure Supplement 4f). 175 
  176 
Regulation of ERK MAPK and AP1 transcription factors 177 
To identify the signalling networks affected by upregulation of phosphatases during 178 
commitment we performed GO analysis of ranked peptides that were dephosphorylated at 4h. 179 
The top enriched pathways were ErbB1 signalling, adherens junctions, insulin signalling and 180 
MAPK signalling (Fig.3a). Several of the proteins we identified are components of more than 181 
one pathway (Fig.3b) and all have been reported previously to regulate epidermal 182 
differentiation (Connelly et al. 2010; Haase et al. 2001; Kolev et al. 2008; Trappmann 2012; 183 
Scholl et al. 2007). In particular, constitutive activation of ERK delays suspension-induced 184 
differentiation (Haase et al. 2001). 185 
 186 
We next ranked protein phosphorylation sites according to the log2-fold decrease at 4 hours, 187 
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plotting the ratio between the change in phosphorylation sites and the change in total protein 188 
(Fig.3-Table Supplement 5). To specifically identify dephosphorylation events, we considered 189 
proteins that increased in abundance by more than 0.5 in log2 space while phosphorylation 190 
levels that remained constant were excluded from the ranking. Consistent with the predicted 191 
dynamic interactions between signalling pathways (Fig.3b), phosphorylation sites on MAPK1 192 
(ERK2) and MAPK3 (ERK1) were identified in the top 15 most decreased sites (Fig.3c). 193 
Other proteins in the top 15 included components or regulators of the cytoskeleton (FLNA), 194 
Rho signalling (DOCK5, ARHGEF16, CIT) and EGFR signalling (EPS8), again consistent 195 
with the GO terminology analysis.  196 
 197 
We performed Western blotting to confirm that ERK1/2 activity was indeed modulated by 198 
suspension-induced terminal differentiation and by the candidate pro-commitment 199 
phosphatases (Fig. 3d, e). As reported previously, the level of phosphorylated ERK1/2 200 
diminished with time in suspension (Janes et al. 2009) (Fig. 3d). siRNA-mediated knockdown 201 
of DUSP6, PPTC7, PTPN1, PTPN13 or PPP3CA resulted in higher levels of phosphorylated 202 
ERK1/2 relative to the scrambled control, both at 0h and at some later time points (Fig.3d, e). 203 
These effects are consistent with the known requirement for ERK MAPK activity to maintain 204 
keratinocytes in the stem cell compartment (Trappmann 2012).  205 
 206 
Transcriptional regulation of epidermal differentiation is mediated by the Activator Protein 1 207 
(AP1) family of transcription factors (Eckert et al. 2013), which is the main effector of the 208 
MAPK and ErbB signalling cascades
 
(Karin & Chang 2001). Quantification of the levels of 209 
AP1 transcripts during suspension-induced terminal differentiation revealed that different 210 
AP1 factors changed with different kinetics, as reported previously (Gandarillas & Watt 211 
1995) (Fig.3f). Notably, the level of several members of the MAF subfamily of AP1 factors 212 
(MAF, MAFB and MAFG) significantly increased during differentiation, consistent with 213 
recent evidence that they mediate the terminal differentiation program in human keratinocytes
 
214 
(Lopez-Pajares et al. 2015). In line with these observations, knockdown of individual pro-215 
commitment phosphatases reduced the induction of MAF AP1 factors in suspension (Fig. 3f; 216 
Fig.3-Table Supplement 6). These experiments are consistent with a model whereby induction 217 
of phosphatases in committed keratinocytes causes dephosphorylation of ERK MAPK and 218 
prevents the increase in expression of AP1 transcription factors that execute the terminal 219 
differentiation program.  220 
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 221 
Given that DUSP10 knockdown differed from the other protein phosphatases in decreasing 222 
the clonogenicity (Fig.2b; Fig.2-Figure Supplement 3a) and growth rate of keratinocytes 223 
(Fig.2-Figure Supplement 3b, e), we examined the effect of DUSP10 knockdown on ERK1/2 224 
activity and AP1 factor expression. Unlike knockdown of DUSP6, PPTC7, PTPN1, PTPN13 225 
or PPP3CA, knockdown of DUSP10 (Fig.3-Figure Supplement 6a, b) did not increase 226 
ERK1/2 activity (Fig.3g, h). Consistent with its known regulation of p38 MAPK
 
(Caunt & 227 
Keyse 2013), DUSP10 knockdown increased phospho-p38 at 0h; however, this effect was not 228 
observed at later times in suspension (Fig.3-Figure Supplement 6c, d). When the effects of 229 
DUSP10 knockdown on AP1 transcription factors was compared with those of DUSP6, it was 230 
clear that these phosphatases differentially regulated several AP1 factors, including members 231 
of the JUN, FOS and MAF subfamilies (Fig. 3i; Fig.3-Table Supplement 7).  232 
 233 
We confirmed the differing effects of DUSP10 and DUSP6 on cell fate by using either 234 
Cumate or Doxycycline inducible overexpression in human keratinocytes (Fig. 3j; Fig.3-235 
Figure Supplement 6e-g). Whereas overexpression of DUSP10 increased colony formation, 236 
overexpression of DUSP6 reduced clonal growth (Fig. 3j). A dominant negative mutant of 237 
DUSP6 (C293S) lacking phosphatase activity (Okudela et al. 2009) had no effect (Fig. 3j; 238 
Fig.3-Figure Supplement 6f, g).  239 
 240 
A protein phosphatase interaction network acts as a switch to transition cells between 241 
the stem and differentiated cell compartments 242 
We next examined whether the 6 phosphatases we identified experimentally could form a 243 
single phosphatase-phosphatase interaction network governing commitment and 244 
differentiation. To do so, we employed a Boolean network abstraction and constructed a 245 
model in which all phosphatases, DUSP6, PPTC7, PTPN1, PTPN13, PPP3CA and DUSP10, 246 
were allowed to interact either positively or negatively (Fig.4-Figure Supplement 7a). For this 247 
we utilised the concept of an Abstract Boolean Network (ABN) (Yordanov et al. 2016), 248 
which by assigning definite or possible interactions, implicitly defines approximately 10
17
 249 
concrete different Boolean network models (Fig.4-Figure Supplement 7a). In accordance with 250 
this modelling formalism, we abstracted discretised gene expression levels as ‘on’ or ‘off’ if 251 
their mean expression was respectively higher or similar/lower than the average of all genes 252 
(Fig.4-Table Supplement 8). From the set of all possible network topologies (the ABN), we 253 
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sought to test whether there would be a network topology consistent with the discretized gene 254 
expression states over the differentiation time course. To this end, we employed the 255 
automated reasoning approach encapsulated in the tool RE:IN, as described by Dunn et al. 256 
(2014). We encoded a set of experimental constraints comprising the different time points 257 
analysed during suspension-induced differentiation (Fig.1a). These constraints define whether 258 
each gene should be on or off at each time step along the differentiation trajectory (Materials 259 
and Methods). Using this approach we formally deduced that a single Boolean network was 260 
unable to recapitulate the measured gene expression dynamics (Fig.4-Figure Supplement 7a).  261 
 262 
As we were not able to find a single interaction network enough to model the discretized gene 263 
expression states, we further investigated each individual time point to identify whether the 264 
network topology might differ over the time course in suspension. To obtain the necessary 265 
experimental data to identify critical network interactions, we performed individual 266 
knockdowns of the phosphatases after 0, 4, 8 or 12h in suspension. Next we measured by RT-267 
qPCR the effect that each individual knockdown had on the mRNA level of any of the other 268 
phosphatases (Fig.4-Figure Supplement 8a) at each time point. We used the fold-change of 269 
the interaction to inform its directionality (activating or inhibitory) only if it was statistically 270 
significant (p-value<0.05, Fig.4-Table Supplement 9). This led to the inferred mechanistic 271 
networks depicted in Fig. 4a, where the node colours show fold-change in each phosphatase 272 
with time in suspension, relative to the 0h time-point. Arrows indicate positive effects on 273 
expression and T-bars show inhibitory effects. These networks reveal different interactions at 274 
play at each of the time points, suggesting that the network topology reconfigures during 275 
commitment and differentiation. 276 
 277 
In light of these inferred mechanistic interactions, we again employed a Boolean network 278 
abstraction to explore the dynamics of epidermal stem cell commitment. Using the discretised 279 
gene expression levels defined above (Fig.4-Table Supplement 8), we sought to test whether 280 
the network topologies derived for each time point (Fig.4a, b) were consistent with the data. 281 
For this we used an extension of RE:IN, called RE:SIN, which allows the user to explore 282 
switching networks, as described by Shavit et al. (2016). RE:SIN allowed us to determine 283 
whether the inferred networks could recapitulate the dynamic changes in gene expression by 284 
similarly encoding these as expected states on the commitment trajectory (Fig.4-Figure 285 
Supplement 7b). We first found that the networks inferred by the genetic knockdown 286 
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experiments could not satisfy the experimental constraints. This suggested that there were 287 
additional interactions between the phosphatases. To identify such interactions, we analysed 288 
the effect that each individual knockdown had on the protein levels of the other phosphatases 289 
(Fig.4-Figure Supplement 8d; Fig.4-Table Supplement 10) and the effect of DUSP6 and 290 
DUSP10 overexpression on phosphatase mRNA levels (Fig.4-Figure Supplement 8e). We 291 
included those as possible interactions, again using the concept of an ABN at each time step 292 
(Fig.4-Figure Supplement 7c; Fig.4-Table Supplement 8). 293 
 294 
By defining an ABN at each time point that incorporates the possible phosphatase interactions 295 
deduced from the knockdown experiments, we found that the experimental constraints could 296 
be satisfied. Furthermore, our analysis revealed which of the possible interactions were 297 
required to meet these constraints. These could therefore be considered as definite interactions 298 
(Fig.4c, compare with Fig.4-Figure Supplement 7c). We thus used the approach encapsulated 299 
in RE:SIN to uncover the networks governing differentiation at each time point.  300 
 301 
The Boolean network analysis indicates a key role for DUSP6 at commitment (4h), when 302 
DUSP6 expression is positively regulated by all the other phosphatases in the network and by 303 
a self-activating loop (Fig.4a). In contrast, at all other time points the interactions between 304 
individual phosphatases were predominantly negative. Several phosphatases, including 305 
PTPN1 and PTPN13, showed positive autoregulation at one or more time point. It is also 306 
notable that DUSP10 was predominantly negatively regulated by other phosphatases, except 307 
at 4h, when it was positively regulated by PTPN1 and by an autoregulatory loop (Fig.4a).  308 
 309 
To test the robustness of the network we examined the effects of treating keratinocytes with 310 
the histone deacetylase inhibitor Trichostatin A (TSA) and a Protein Kinase C inhibitor 311 
(PKCi). Both drugs blocked suspension-induced terminal differentiation, as measured by 312 
expression of IVL and TGM1, and prevented downregulation of ITGα6 (Fig.4-Figure 313 
Supplement 8b, c). However, cells treated with TSA still underwent commitment, as 314 
evaluated by loss of colony forming ability and downregulation of TP63, whereas those 315 
treated with the PKC inhibitor did not. At 12h in suspension both drugs reduced expression of 316 
DUSP10 and PTPN13 and increased expression of DUSP6 and PPTC7 relative to untreated 317 
cells; however, they differentially affected PPP3CA and PTPN1 (Fig.4d). 318 
 319 
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We next used our modelling approach to test whether network switching still occurs under 320 
PKCi and TSA treatment using the constrained ABNs that we derived for each stage. As 321 
before, we discretised gene expression levels from these experiments as ‘on’ or ‘off’ (Fig.4-322 
Table Supplement 8). Under both treatments, we found that we could not transit through the 323 
networks while respecting the expected expression states, corroborating the experimental 324 
findings that terminal differentiation is blocked in these conditions. The PKCi phosphatase 325 
expression pattern at 12h was compatible with the phosphatase interaction network derived at 326 
0h, supporting the conclusion that PKCi arrests cells in the stem cell compartment. In TSA-327 
treated cells the network must switch from that derived at 0h to that derived at 4h, and 328 
subsequently to that derived at 8h, or straight from 0h to 8h. Neither PKCi nor TSA treatment 329 
resulted in an expression pattern compatible with the network derived at 12h for untreated 330 
cells, consistent with the inhibition of differentiation. 331 
 332 
The above findings can be summarised using dynamical systems terminology. Epidermal 333 
differentiation can be described by two saddle-node bifurcations (Fig.4e, f). We start with a 334 
single minimum that corresponds to a stable state: the stem cell. Then we pass through a first 335 
saddle-node bifurcation where we have two minima, so the system can switch from one state 336 
to the other and this corresponds to commitment. Next the global minimum changes and we 337 
finally have a second saddle-node bifurcation that leads again to a single steady state, which 338 
corresponds to the differentiated cells
 
(Zhang et al. 2012). From here the stem cell state and 339 
the terminally differentiated state emerge as stable states, while commitment is inherently 340 
unstable and serves as a biological switch. 341 
 342 
Protein phosphatase expression is patterned within human epidermis and responds to 343 
topographical cues 344 
Given the role of the protein phosphatases in regulating commitment of keratinocytes in 345 
suspension, we examined whether phosphatase expression was also subject to spatial 346 
regulation, since spatiotemporal coordination of stem cell behaviour contributes to epidermal 347 
homeostasis
 
(Doupé & Jones 2012). By wholemount labelling the basal layer of sheets of 348 
human epidermis
 
(Jensen et al. 1999) we found that DUSP6, PTPN1 and PPP3CA were most 349 
highly expressed in cells with the highest levels of β1 integrin or 6 integrin, which 350 
correspond to stem cell clusters (Jensen et al. 1999) (Fig.4g; Fig.4 – Figure Supplement 9a,b). 351 
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In contrast, PPTC7 was enriched in the integrin-low regions, while PTPN13 and DUSP10 352 
were more uniformly expressed throughout the basal layer (Fig.4g; Fig.4 – Figure 353 
Supplement 9a,b). The inverse relationship between the patterns of PPP3CA and PPTC7 354 
expression is in good agreement with the network analysis demonstrating negative regulation 355 
of PPP3CA by PPTC7 in undifferentiated keratinocytes (0h; Fig.4a).  356 
 357 
The patterned distribution of phosphatases could be recreated in vitro by culturing 358 
keratinocytes on collagen-coated PDMS elastomer substrates that mimic the topographical 359 
features of the human epidermal-dermal interface
 
(Viswanathan et al. 2016). We observed 360 
clusters of cells with high levels of DUPS6 on the tops of the features, where stem cells 361 
expressing high levels of β1 integrins accumulate (Viswanathan et al. 2016) (Fig.4h). In 362 
contrast, DUSP10 was uniformly expressed regardless of cell position (Fig.4h). These results 363 
indicate that the phosphatases are subject to spatial regulation that is independent of signals 364 
from cells in the underlying dermis.  365 
 366 
Discussion 367 
We have presented evidence that epidermal commitment is a biological switch controlled by a 368 
network of protein phosphatases that are regulated spatially and temporally. Applying 369 
Boolean network analysis to our experimental data, we were unable to recapitulate the 370 
observed changes in phosphatase gene expression using a single ABN, but we could do so by 371 
implementing a scheme of network switching. This led us to conclude that the interactions 372 
among the commitment phosphatases change in the course of differentiation. The negative 373 
feedback loops predominating at 0h, 8h and 12h are known to result in stable phenotypes 374 
because the network is able to counteract additional inputs
 
(Zeigler et al. 2000). However, at 375 
4h all but one of the interactions were positive. Positive feedback loops lead to instability, 376 
because the network amplifies any inputs it receives. This supports the concept of 377 
commitment as an unstable state, which aligns with the experimental evidence of that 378 
happening within a defined temporal window.  379 
 380 
The key role of DUPS6 at commitment fits well with its upregulation by Serum Response 381 
Factor, which is known to control keratinocyte differentiation (Connelly et al. 2010), and its 382 
importance in controlling the activation kinetics and dose-response behaviour of ERK MAPK 383 
signalling (Blüthgen et al. 2009). However, the involvement of multiple phosphatases in 384 
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commitment may protect cells from undergoing premature terminal differentiation. 385 
Furthermore, their patterned distribution within the epidermal basal layer would be consistent 386 
with different phosphatases regulating commitment in different positions along the basement 387 
membrane, and with the ability of different external stimuli to trigger differentiation via 388 
different intracellular pathways (Watt 2016).  389 
 390 
The upregulation of basal layer markers in the suprabasal epidermal layers on knockdown of 391 
pro-commitment phosphatases mimics features of psoriatic lesions in which ERK is known to 392 
be upregulated (Haase et al. 2001). In particular, in the epidermal reconstitution assays there 393 
was suprabasal expression of Ki67 and TP63, with TP63+ cells co-expressing IVL. These 394 
observations lead us to speculate that commitment is abnormally stabilised in psoriasis, as 395 
observed in TSA treated keratinocytes in suspension. Given that protein phosphatases within 396 
the commitment network are known to regulate expression of inflammatory cytokines (Caunt 397 
& Keyse 2013), deregulated phosphatase expression could potentially contribute to the 398 
pathophysiology of psoriasis.  399 
 400 
In conclusion, the simple experimental model of suspension-induced keratinocyte 401 
differentiation has enabled us to capture some of the complex transcriptional and post-402 
translational events that control the transition from the stem to the differentiated cell 403 
compartment. We now have the opportunity to explore, systematically, the key upstream and 404 
downstream regulators of protein phosphatases during epidermal homeostasis, injury and 405 
disease.  406 
 407 
 408 
Methods 409 
Cell culture Primary human keratinocytes (strain km) were isolated from neonatal foreskin 410 
and cultured on mitotically inactivated 3T3-J2 cells in complete FAD medium, containing 1 411 
part Ham's F12, 3 parts Dulbecco's modified eagle medium (DMEM), 10
−4
 M adenine, 10% 412 
(v/v) FBS, 0.5 μg ml−1 hydrocortisone, 5 μg ml−1 insulin, 10−10 M cholera toxin and 10 ng 413 
ml
−1
 EGF, as described previously
 
(Gandarillas & Watt 1995). Prior to suspension-induced 414 
differentiation in methylcellulose
 
(Adams & Watt 1989) we enriched for stem cells by 415 
filtering the disaggregated keratinocytes twice through a 40µm sterile membrane. For 416 
knockdown or overexpression experiments, keratinocytes were grown in Keratinocyte-SFM 417 
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medium (Gibco) supplemented with 0.15 ng/ml EGF and 30 μm/ml BPE. All isoforms of 418 
PKC were inhibited using 5 μM GF 109203X (Tocris; at lower concentrations GF190203X 419 
preferentially inhibits the -α and -β isoforms) and histone deacetylase was inhibited with TSA 420 
(Sigma Aldrich). PDMS substrates that mimic the topography of the epidermal-dermal 421 
junction were generated as described previously
 
(Viswanathan et al. 2016).  422 
 423 
Genome-wide expression profiling Genome-wide expression profiling was performed using 424 
the Illumina BeadArray platform and standard protocols. Data were processed using R 425 
(http://www.r-project.org/) or Genespring GX13.1 software. The gene expression data are 426 
deposited in the GEO databank (GSE73147). 427 
 428 
Computational analysis of gene expression datasets Microarray initial processing and 429 
normalisation were performed with BeadStudio software. BeadChip internal p-values 430 
(technical bead replicates) were used to identify genes significantly expressed above the 431 
background noise. To filter out genes with signals that were not significant, a p-value of 0.05 432 
was used as the cut-off value and only genes with a p-value <0.05 in at least one sample 433 
passed the filter. From the original set of 34,685 gene targets, 23,356 targets met this 434 
criterion. The data were imported into GeneSpring v13, normalised using quantile 435 
normalisation and the biological replicates averaged for subsequent analysis. We performed 436 
pairwise comparison between 0h and 4, 8 and 12h. Genes showing a fold change higher than 437 
2 comparing to control (and both p-values were significant) were subjected to GO analysis 438 
with GeneSpring v13 (152 genes between 4h and 0h, 553 between 8 and 0h, 1136 genes 439 
between 12 and 0h). Hierarchical clustering based on Pearson’s uncentered distance was 440 
performed on time course gene expression data and the results presented as a heatmap. 441 
Additionally, t-SNE plots were generated for the transcriptomics data using the t-sne package 442 
for R. 443 
 444 
Analysis of mechanistic networks A 2-way ANOVA with multiple comparisons corrected 445 
using the Holm-Sidak test was used to identify the statistically significant effects of single 446 
phosphatase knock-down on the expression of the other phosphatases (pij, Fig.4 – table 447 
supplement 9). The weight of each edge was calculated as the inverse p-value for the 448 
respective interaction (wij = 1/pij). For simplicity we kept only the significant links (p-449 
value<0.05). The networks depicted in Fig. 4a were drawn with Cytoscape (cytoscape.org, 450 
15 
 
V3.2.1). 451 
 452 
Dynamic Boolean network analysis The Boolean network analysis was performed using 453 
RE:IN and RE:SIN software, which is designed to encode and test whether a single or set of 454 
Boolean networks are consistent with observed changes in gene expression states. The 455 
methodology has been described previously (Yordanov et al. 2016; Shavit et al. 2016). 456 
Briefly, a set of possible and definite interactions comprises an Abstract Boolean Network 457 
(ABN), which implicitly defines a set of concrete Boolean networks. Each concrete network 458 
has a unique topology defined by the different combinations of the possible interactions, 459 
which can be present or absent. This allows the user to explore alternative model topologies, 460 
and to test the requirement for different interactions that are suggested by experimental data. 461 
The software allows the user to seek the set of concrete Boolean network models that are 462 
consistent with a set of experimental constraints, and then to use this constrained set of 463 
models to make predictions of untested behaviour. Experimental constraints are defined as 464 
expected states along network trajectories (Fig.4b), which are constructed from discretised 465 
gene expression patterns. The software is freely available to use, and can be accessed together 466 
with tutorials and FAQ at research.microsoft.com/rein. 467 
 468 
We considered Boolean networks with synchronous updates, such that each gene in the 469 
network updates at each step in the network trajectory. Logical update functions for each 470 
gene, which define how the gene switches on or off in response to its regulators, were as 471 
defined by Yordanov et al. (2016). We first used RE:IN to test whether a single network (one 472 
that does not switch along the differentiation trajectory) is consistent with the observed 473 
changes in gene expression. We tested all possible single networks by allowing possible 474 
positive and negative interactions between each pair of genes. None of these networks were 475 
found to be consistent with the gene expression changes. We next constructed a switching 476 
problem in which we defined four ABNs, which individually correspond to the time points 477 
measured in our knockdown experiments. We defined the allowable network switching to be 478 
monotonic: networks can progress forward in time (i.e. 0h to 4h, 0h to 8h etc.) but not 479 
backwards (i.e. 8h cannot switch to 4h or 0h). We then used RE:SIN to test whether it was 480 
possible to find a sequence of networks that allowed the gene expression changes to be 481 
satisfied. We found that this was possible, and, furthermore, identified interactions that were 482 
required / disallowed to meet the constraints (Fig.4c). 483 
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 484 
Defining constraints for Boolean network analysis The network governing differentiation 485 
must be consistent with observed changes in gene expression patterns over time. To 486 
investigate whether a given network could recapitulate the observed behaviour, we defined 487 
the expected states along a differentiation trajectory starting from the initial gene expression 488 
state at 0h. Three experimental constraints were defined, corresponding to measured gene 489 
expression changes at specific time points during suspension-induced differentiation, PKC 490 
inhibition and TSA treatment (Fig.4b). Individual gene expression measurements were 491 
discretised as ‘on’ or ‘off’ if their mean expression was respectively higher or similar/lower 492 
than the average of all genes. We set one step in the network trajectory to correspond to one 493 
hour in the time course, such that we defined expected gene expression states at 0h, 4h, 8h 494 
and 12h.  495 
 496 
Generation and analysis of SILAC LC-MS/MS datasets A pre-confluent keratinocyte 497 
culture was split into two separate cultures with FAD
-lysine-arginine
 medium (Sigma) 498 
differentially supplemented either with K
0
R
0 
or with K
8
R
10
 (stable isotopes of amino acids 499 
Lysine and Arginine; Cambridge Isotope Laboratories) (Ly et al. 2014). FCS used for SILAC 500 
medium was also depleted of Lysine and Arginine (Sigma). Cells were grown in SILAC 501 
medium for 5-6 days to reach 70 – 80% confluence and later harvested for downstream 502 
assays. Light labelled cells served as the 0h sample whereas heavy labelled cells were 503 
suspended in methylcellulose and harvested at 4, 8 and 12h. Cell extracts prepared from 0h 504 
cells were mixed individually with 4, 8 and 12h samples at a 1:1 ratio of total protein. The 505 
mixed samples were then subjected to mass spectrometry (MS).  506 
 507 
For measurement of protein abundance changes by SILAC, lysates containing ~80 µg protein 508 
were prepared in LDS sample buffer containing reducing agent (TCEP). Proteins were 509 
separated by electrophoresis on a 4-12% Bis-Tris NuPAGE gel, which was Coomassie-510 
stained and cut into eight equally sized gel slices. Gel-embedded proteins were reduced with 511 
TCEP, alkylated with iodoacetamide, and trypsin-digested to release peptides. Peptides were 512 
extracted from gels using 50% acetonitrile (ACN) containing 5% formic acid (FA), dried and 513 
resuspended in 5% FA. Peptides were then analysed by LC-MS/MS on a Dionex RSLCnano 514 
coupled to a Q-Exactive Orbitrap classic instrument. Specifically, peptides were loaded onto a 515 
PepMap100 75µm x 2cm trap column, which was then brought in-line with a 75µm x 50cm 516 
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PepMap-C18 column and eluted using a linear gradient over 220 min at a constant flow rate 517 
of 200 nl/min. The gradient composition was 5% to 35% B, where solvent A = 2% ACN + 518 
0.1% FA and solvent B = 80% ACN + 0.1% FA. Peptides were eluted with a linear elution 519 
gradient (5% B to 35% B) over 220 min with a constant flow rate of 200 nl/min. An initial 520 
MS scan of 70,000 resolution was acquired, followed by data-dependent MS/MS by HCD on 521 
the top 10 most intense ions of ≥2+ charge state at 17,500 resolution.  522 
 523 
For phosphoenrichment analysis, lysates containing ~2 mg of protein were 524 
chloroform:methanol-precipitated. Pellets were resuspended in 8M urea in digest buffer (0.1 525 
M Tris pH 8 + 1 mM CaCl2), diluted to 4 M urea with additional digest buffer, and digested 526 
with Lys-C for 4h at 37°C. The digests were diluted to 1M urea and trypsin-digested 527 
overnight at 37°C. Digests were then acidified and desalted using SepPak-C18 vacuum 528 
cartridges. Desalted peptides were resuspended in mobile phase A for HILIC (80% ACN + 529 
0.1% TFA). HILIC chromatography was performed using a Dionex Ultimate 3000 with a 530 
TSK Biosciences Amide-80 column (250 x 4.6 mm)
 
(Di Palma et al. 2013; McNulty & Annan 531 
2008; Navarro et al. 2011). Peptides were eluted using an exponential gradient (80% B to 532 
60% B) composed of A (above) and B (0.1% TFA) at 0.4 ml/min over 60 min. 16 fractions 533 
were collected from 25 min to 60 min. These fractions are enriched for hydrophilic peptides, 534 
including phosphopeptides. The fractions were dried before further phosphoenrichment by 535 
titanium dioxide (TiO2). 536 
 537 
For TiO2 enrichment, HILIC fractions were resuspended in loading buffer (70% ACN + 0.3% 538 
lactic acid + 3% TFA). 1.25 mg of TiO2 (GL Sciences) was added to each fraction and 539 
incubated for 10 min to bind phosphopeptides. Beads were washed with loading buffer, and 540 
two wash buffers, composed of (1) 70% ACN + 3% TFA and (2) 20% ACN + 0.5% TFA. 541 
Phosphopeptides were eluted in two steps, first with 4% of ammonium hydroxide solution 542 
(28% w/w NH3) in water for 1h and again with 2.6% of ammonium hydroxide solution in 543 
50% ACN overnight. Elutions were collected, dried, resuspended in 5% FA and analysed by 544 
LC-MS/MS. The LC-MS analysis was performed similarly to above with the following 545 
modifications: peptides were chromatographed on an EasySpray PepMap 75 µm x 50 cm 546 
column, and a ‘Top30’ method was used where the top 30 most intense ions were chosen for 547 
MS/MS fragmentation. Raw data were then processed using MaxQuant, which implements 548 
the Andromeda search engine, for peptide and protein identification and SILAC quantitation.  549 
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 550 
For the proteomics dataset, 1155 out of 2024 probes had a significant p-value<0.05 551 
(calculated in MaxQuant). To identify differentially expressed proteins between time 0 and 4, 552 
8 and 12h we collected per time point the proteins whose absolute ratios were >0.5. For each 553 
time point, the proteins were then split whether the ratio was positive or negative. 6 lists were 554 
annotated for GO terminology using GeneSpring. The extensive list of GO-terms was 555 
submitted to Revigo
 
(Supek et al. 2011) to reduce complexity and the resulting GO-categories 556 
depicted in Extended Data Fig. 1f. The mass spectrometry proteomics data have been 557 
deposited with the ProteomeXchange Consortium via the PRIDE partner repository with the 558 
dataset identifier PXD003281. 559 
 560 
siRNA nucleofection siRNA nucleofection was performed with the Amaxa 16-well shuttle 561 
system (Lonza). Pre-confluent keratinocytes were disaggregated and resuspended in cell line 562 
buffer SF. For each 20μl transfection (program FF-113), 2 × 105
 
cells were mixed with 1–2 563 
μM siRNA duplexes as described previously (Mulder et al. 2012). Transfected cells were 564 
incubated at ambient temperature for 5–10 min and subsequently replated in pre-warmed 565 
Keratinocyte-SFM medium until required for the downstream assay. SMART pool ON-566 
TARGET plus siRNAs (Ambion/GE Healthcare) were used for gene knockdowns. Each 567 
SMART pool was a mix of 4 sets of RNAi oligos. The sequences of the siRNA oligos are 568 
provided in the Supplementary  Table 11.  569 
 570 
shRNA infection shRNA lentiviral vectors were purchased from Sigma-Aldrich (Mission 571 
shRNA). 2 shRNA per target were chosen. Their sequences are listed in Supplementary Table 572 
12. Primary keratinocytes were transduced with lentiviral particles for 48h, before being 573 
subjected to 2 μg/ml Puromycin selection for 72h. Cells were then expanded for experimental 574 
analysis.  575 
 576 
Doxycycline and Cumate inducible overexpression For the Doxycycline inducible system 577 
we used the pCW57-GFP-2A-MCS lentiviral vector (gift from Adam Karpf; Addgene 578 
plasmid # 71783). Primary keratinocytes were transduced with lentiviral particles containing 579 
protein expression vector encoding genes for wild type DUSP6, mutant DUSP6
C293S
 and 580 
DUSP10. 2 days post-transduction, cells were subjected to 2 μg/ml Puromycin selection for 3 581 
days and then 1µg/ml Doxycycline was added to the growth medium.  582 
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 583 
For Cumate induction we used the lentiviral QM812B-1 expression vector (System 584 
Biosciences). Cells were transduced and selected as described for the Doxycycline system and 585 
protein expression was induced by addition of 30 µg/ml Cumate solution to the growth 586 
medium.  587 
 588 
Clonogenicity assays 100, 500 or 1000 keratinocytes were plated on a 3T3 feeder layer per 589 
10cm
2
 dish or per well of a 6 well dish. After 12 days feeders were removed and keratinocyte 590 
colonies were fixed in 10% formalin (Sigma) for 10 min then stained with 1% Rhodanile Blue 591 
(1:1 mixture of Rhodamine B and Nile Blue A [Acros Organics]). Colonies were scored using 592 
ImageJ and clonogenicity was calculated as the percentage of plated cells that formed 593 
colonies. 594 
 595 
Skin reconstitution assays Pre-confluent keratinocyte cultures (km passage 3) were 596 
disaggregated and transfected with SMART pool siRNAs or non-targeting control siRNAs, or 597 
with lentiviral shRNAs. 24 hours post-siRNA transfection or >7 days post shRNA infection, 598 
keratinocytes were collected and reseeded on irradiated de-epidermised human dermis
 
(Sen et 599 
al. 2010) in 6-well Transwell plates with feeders and cultured at the air–liquid interface for 600 
three weeks. The cultures were then fixed in 10% neutral buffered formalin (overnight), 601 
paraffin embedded and sectioned for histological staining. 6μm thick sections were labelled 602 
with haematoxylin and eosin or appropriate antibodies. H&E stained images were acquired 603 
with a Hamamatsu slide scanner and analysed using NanoZoomer software (Hamamatsu). 604 
 605 
Automated analysis of skin reconstitution assay H&E stained sections were acquired with 606 
a Hamamatsu slide scanner and analysed in Python. Briefly, tissue sections were 607 
automatically detected based on k-means segmentation, and colours were rebalanced. The 608 
epidermis was then isolated by colour separation (extraction of haematoxylin color channels 609 
by a deconvolution algorithm) (Ruifrok & Johnston 2001). After performing an automatic 610 
thresholding, epidermal area was measured by pixel counting. To measure epidermal 611 
thickness, the area was divided by a 1-pixel wide reduced-topology (van der Walt et al. 2014). 612 
Full script is available as Supplementary Source Code OrganotypicAutomatedQuant.py . 613 
 614 
Immunofluorescence staining of cultured cells and reconstituted skin For IVL staining of 615 
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cells in suspension, cells were recovered from methylcellulose, spun down onto a slide using 616 
a Cytospin and then fixed with 4% paraformaldehyde. Sections of paraffin embedded 617 
reconstituted skin were dewaxed, rehydrated and subjected to heat-mediated antigen retrieval. 618 
Immunofluorescence labelling of cells and sections was performed with the appropriate 619 
antibodies. Wherever indicated, DAPI was used to label nuclei. Image acquisition was 620 
performed using a Nikon A1 confocal microscope (Nikon Instruments Inc.). To determine % 621 
antibody labelled cells in sections, the total numbers of labelled cells and DAPI+ cells were 622 
assessed in Image J using the Cell Counter plugin. To determined the number of labelled cells 623 
per m of basement membrane, the number of labelled cells was divided by the length of the 624 
basement membrane. 625 
 626 
Western blotting Cells were lysed on ice in 1x RIPA buffer (Bio-Rad) supplemented with 627 
protease and phosphatase inhibitor cocktails (Roche). Total protein was quantified using a 628 
BCA kit (Pierce). Soluble proteins were resolved by SDS-PAGE on 4-15% Mini-PROTEAN 629 
TGX gels (Bio-Rad) and transferred onto Trans-Blot 0.2um PVDF membranes (Bio-Rad) 630 
using the Trans-Blot Turbo transfer system (Bio-Rad). Primary antibody probed blots were 631 
visualized with appropriate horseradish peroxidase-coupled secondary antibodies using 632 
enhanced chemiluminescence (ECL; Amersham). The ChemiDoc Touch Imaging System 633 
(Bio-Rad) was used to image the blots. Quantification of detected bands was performed using 634 
Image Lab software (Bio-Rad). Uncropped versions of the western blot presented in that 635 
manuscript are available in Figure Supplement 10. 636 
 637 
Epidermal wholemounts The procedure was modified from previous reports
 
(Jensen et al. 638 
1999). Skin samples from either breast or abdomen were obtained as surgical waste with 639 
appropriate ethical approval and treated with Dispase (Corning) overnight on ice at 4
o
C. The 640 
epidermis was peeled off as an intact sheet and immediately fixed in 4% paraformaldehyde 641 
for 1 hour. Fixed epidermal sheets were washed and stored in PBS containing 0.2% sodium 642 
azide at 4°C. Sheets were stained with specific antibodies in a 24-well tissue culture plate. 643 
Image acquisition was performed using a Nikon A1 confocal microscope. 3D maximal 644 
projection (1,024 × 1,024 dpi), volume rendering and deconvolution on stacked images were 645 
generated using NIS Elements version 4.00.04 (Nikon Instruments Inc.).  646 
 647 
Antibodies Antibodies against the following proteins were used: P-ERK (Cell Signaling # 648 
21 
 
9101; western blot – 1:1000 dilution), ERK (Cell Signaling # 9102; western blot – 1:1000), P-649 
p38 (Cell Signaling # 9211; western blot – 1:1000), p38 (Cell Signaling # 9212; western blot 650 
– 1:1000), Cyclophilin B (R&D # MAB5410; western blot – 1:4000), MKP-3/DUSP6 651 
(Abcam # ab76310; western blot - 1:1000 and R&D Systems # MAB3576-SP; 652 
immunostaining – 1:200), PPTC7 (Abcam # ab122548; western-blot 1:250 and Sigma # 653 
HPA039335; immunostaining – 1:200), PTPN1/PTP1B (Sigma # HPA012542; western-blot - 654 
1:500; R&D Systems # AF1366-SP; immunostaining – 1:200), PTPN13 (R&D Systems # 655 
AF3577; western-blot - 1:300 and immunostaining – 1:200), PPP3CA/Calcineurin A (Sigma 656 
# HPA012778; western-blot 1/1000 and R&D Systems # MAB2839-SP; immunostaining – 657 
1:200), DUSP10 (Abcam # 140123; western-blot - 1:1000 and immunostaining – 1:200), 658 
TP63 (SCBT # sc-8431 or Abcam # ab735; immunostaining – 1:100), Involucrin (SY5, in-659 
house; immunostaining – 1:500, or DH1, in-house; immunostaining – 1:200), Ki67 (Abcam # 660 
ab16667; immunostaining – 1:100) and β1-Integrin (clone P5D2, in-house; immunostaining – 661 
1:200). Species-specific secondary antibodies conjugated to Alexa 488 or Alexa 594 were 662 
purchased from Molecular Probes, and HRP-conjugated second antibodies were purchased 663 
from Amersham and Jackson ImmunoResearch. 664 
 665 
RNA extraction and RT–qPCR Total RNA was isolated using the RNeasy kit (Qiagen). 666 
Complementary DNA was generated using the QuantiTect Reverse Transcription kit 667 
(Qiagen). qPCR analysis of cDNA was performed using qPCR primers (published or 668 
designed with Primer3) and Fast SYBR green Master Mix (Life Technologies). RT-qPCR 669 
reactions were run on CFX384 Real-Time System (Bio-Rad). Heatmaps of RT-qPCR data 670 
were generated by Multiple Expression Viewer (MeV_4_8) or GraphPad Prism 7. Sequences 671 
of qPCR primers are provided in Supplementary Table 13. 672 
 673 
Statistics Statistical analysis of the quantifications presented in the Figure legends was 674 
performed using GraphPad Prism 7. 675 
 676 
References 677 
 678 
Adams, J.C. & Watt, F.M., 1989. Fibronectin inhibits the terminal differentiation of human 679 
keratinocytes. Nature, 340(6231), pp.307–309. 680 
Avraham, R. & Yarden, Y., 2011. Feedback regulation of EGFR signalling: decision making by early 681 
22 
 
and delayed loops. Nature Publishing Group, 12(2), pp.104–117. 682 
Blüthgen, N. et al., 2009. A systems biological approach suggests that transcriptional feedback 683 
regulation by dual-specificity phosphatase 6 shapes extracellular signal-related kinase activity in 684 
RAS-transformed fibroblasts. FEBS Journal, 276(4), pp.1024–1035. 685 
Caunt, C.J. & Keyse, S.M., 2013. Dual specificity MAP kinase phosphatases (MKPs). The FEBS 686 
Journal, 280(2), pp.489–504. 687 
Connelly, J.T. et al., 2010. Actin and serum response factor transduce physical cues from the 688 
microenvironment to regulate epidermal stem cell fate decisions. Nature Cell Biology, 12(7), 689 
pp.711–718. 690 
Di Palma, S. et al., 2013. Finding the same needles in the haystack? A comparison of phosphotyrosine 691 
peptides enriched by immuno-affinity precipitation and metal-based affinity chromatography. 692 
Journal of Proteomics, 91(C), pp.331–337. 693 
Doupé, D.P. & Jones, P.H., 2012. Interfollicular epidermal homeostasis: dicing with differentiation. 694 
Experimental dermatology, 21(4), pp.249–253. 695 
Dunn, S.J. et al., 2014. Defining an essential transcription factor program for naïve pluripotency. 696 
Science (New York, N.Y.), 344(6188), pp.1156–1160. 697 
Eckert, R.L. et al., 2013. AP1 Transcription Factors in Epidermal Differentiation and Skin Cancer. 698 
Journal of Skin Cancer, 2013(1), pp.1–9. 699 
Gandarillas, A. & Watt, F.M., 1995. Changes in expression of members of the fos and jun families and 700 
myc network during terminal differentiation of human keratinocytes. Oncogene, 11(7), pp.1403–701 
1407. 702 
Haase, I. et al., 2001. A role for mitogen-activated protein kinase activation by integrins in the 703 
pathogenesis of psoriasis. Journal of Clinical Investigation, 108(4), pp.527–536. 704 
Hopkin, A.S. et al., 2012. GRHL3/GET1 and Trithorax Group Members Collaborate to Activate the 705 
Epidermal Progenitor Differentiation Program W. A. Bickmore, ed. PLoS Genetics, 8(7), 706 
p.e1002829. 707 
Janes, S.M. et al., 2009. PI3-kinase-dependent activation of apoptotic machinery occurs on 708 
commitment of epidermal keratinocytes to terminal differentiation. Cell Research, pp.1–12. 709 
23 
 
Jensen, U.B., Lowell, S. & Watt, F.M., 1999. Patterning of human epidermal stem cells. Development, 710 
126, pp.2409–2418. 711 
Karin, M. & chang, L., 2001. Mammalian MAP kinase signalling cascades. Nature, 410, pp.37–40. 712 
Kolev, V. et al., 2008. EGFR signalling as a negative regulator of Notch1 gene transcription and 713 
function in proliferating keratinocytes and cancer. Nature Cell Biology, 10(8), pp.902–911. 714 
Lopez-Pajares, V. et al., 2015. A LncRNA-MAF:MAFB Transcription Factor Network Regulates 715 
Epidermal Differentiation. Developmental Cell, 32(6), pp.693–706. 716 
Ly, T. et al., 2014. A proteomic chronology of gene expression through the cell cycle in human 717 
myeloid leukemia cells. eLife, 3(0), pp.e01630–e01630. 718 
McNulty, D.E. & Annan, R.S., 2008. Hydrophilic interaction chromatography reduces the complexity 719 
of the phosphoproteome and improves global phosphopeptide isolation and detection. Molecular 720 
& Cellular Proteomics, 7(5), pp.971–980. 721 
Mulder, K.W. et al., 2012. Diverse epigenetic strategies interact to control epidermal differentiation. 722 
Nature Cell Biology, 14(7), pp.753–763. 723 
Navarro, M.N. et al., 2011. Phosphoproteomic analysis reveals an intrinsic pathway for the regulation 724 
of histone deacetylase 7 that controls the function of cytotoxic T lymphocytes. Nature 725 
immunology, 12(4), pp.352–361. 726 
Nimmo, R.A., May, G.E. & Enver, T., 2015. Primed and ready: understanding lineage commitment 727 
through single cell analysis. Trends in Cell Biology, 25(8), pp.459–467. 728 
Okudela, K. et al., 2009. Down-Regulation of DUSP6 Expression in Lung Cancer. The American 729 
Journal of Pathology, 175(2), pp.867–881. 730 
Ruifrok, A.C. & Johnston, D.A., 2001. Quantification of histochemical staining by color 731 
deconvolution. Analytical and quantitative cytology and histology. 732 
Scholl, F.A. et al., 2007. Mek1/2 MAPK Kinases Are Essential for Mammalian Development, 733 
Homeostasis, and Raf-Induced Hyperplasia. Developmental Cell, 12(4), pp.615–629. 734 
Schwanhäusser, B. et al., 2011. Global quantification of mammalian gene expression control. Nature, 735 
473(7347), pp.337–342. 736 
24 
 
Semrau, S. & van Oudenaarden, A., 2015. Studying Lineage Decision-Making In Vitro: Emerging 737 
Concepts and Novel Tools. Annu.Rev.Cell Dev.Biol., 31(1), pp.317–345. 738 
Sen, G.L. et al., 2010. DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature, 739 
463(7280), pp.563–567. 740 
Shavit, Y. et al., 2016. Automated Synthesis and Analysis of Switching Gene Regulatory Networks. 741 
Bio Systems, 146, pp.26–34. 742 
Simons, B.D. & Clevers, H., 2011. Strategies for Homeostatic Stem Cell Self-Renewal in Adult 743 
Tissues. Cell, 145(6), pp.851–862. 744 
Supek, F. et al., 2011. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS 745 
ONE, 6(7), p.e21800. 746 
Tan, D.W.M. et al., 2013. Single-cell gene expression profiling reveals functional heterogeneity of 747 
undifferentiated human epidermal cells. Development, 140(7), pp.1433–1444. 748 
Trappmann, B., 2012. Extracellular-matrix tethering regulates stem-cell fate. Nature Materials, 11(7), 749 
pp.642–649. 750 
van der Walt, S. et al., 2014. scikit-image: image processing in Python. PeerJ, 2(2), p.e453. 751 
Viswanathan, P. et al., 2016. Mimicking the topography of the epidermal-dermal interface with 752 
elastomer substrates. Integrative Biology, 8, pp.21–29. 753 
Watt, F.M., 2016. Engineered Microenvironments to Direct Epidermal Stem Cell Behavior at Single-754 
Cell Resolution. Developmental Cell, 38(6), pp.601–609. 755 
Watt, F.M., 2014. Mammalian skin cell biology: at the interface between laboratory and clinic. 756 
Science (New York, N.Y.), 346(6212), pp.937–940. 757 
Yordanov, B. et al., 2016. A Method to Identify and Analyze Biological Programs through Automated 758 
Reasoning. NPJ systems biology and applications, 2(1), p.146. 759 
Zeigler, B.P., Praehofer, H. & Kim, T.G., 2000. Theory of Modeling and Simulation, Academic Press. 760 
Zhang, Y., Ge, H. & Qian, H., 2012. One Dimensional Birth Death Process and Delbrück Gillespie 761 
Theory of Mesoscopic Nonlinear Chemical Reactions. Studies in Applied Mathematics, 129(3), 762 
pp.328–345. 763 
25 
 
 764 
 765 
Supplemental Information This contains Supplementary Figures, Supplementary Tables and 766 
Source Code.  767 
Acknowledgements This research was funded by the Medical Research Council and the 768 
Wellcome Trust. The authors also gratefully acknowledge the use of Core Facilities provided 769 
by the financial support from the Department of Health via the National Institute for Health 770 
Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' 771 
NHS Foundation Trust in partnership with King's College London and King’s College 772 
Hospital NHS Foundation Trust. Bénédicte Oulès is the recipient of fellowships from Societé 773 
Francaise de Dermatologie, Collège des Enseignants en Dermatologie de France and 774 
Fondation d’Entreprise Groupe Pasteur Mutualité. We thank Giacomo Donati, Arsham 775 
Ghahramani and Klaas Mulder for helpful advice and discussions and are grateful to Fredrik 776 
Pontén for providing antibodies.  777 
Author contributions FMW conceived the project. FMW and AIL oversaw the experiments. 778 
AM, BO, TL, K L-A, PV, JN and GW performed and analysed experiments. AM performed 779 
the statistical analysis. AOP and S-JD performed the computational analysis for the Boolean 780 
networks. AOP performed the bioinformatic analysis. MT developed the automated pipeline 781 
for the analysis of the organotypic cultures. AM, BO, AOP and FMW wrote the manuscript. 782 
All authors contributed to preparing the paper. 783 
Author information The authors have no conflicts of interest to declare.  784 
 785 
 786 
Figure legends 787 
Figure 1. Genomic and proteomic analysis identifies protein dephosphorylation events 788 
that correlate with commitment. a. Schematic of experimental design. b. Colony formation 789 
by cells harvested from suspension at different times. Representative dishes are shown 790 
together with % colony formation (n=2 independent experiments, n= 3 dishes per condition 791 
per experiment; p-values calculated by Tukey’s multiple comparison test). c. Cells isolated 792 
from suspension at different time points were labelled with anti-involucrin (IVL) antibody 793 
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(green) and DAPI as nuclear counterstain (blue). IVL-positive cells were counted using 794 
ImageJ (n=3 independent cultures; more than 300 cells counted per condition. p-value 795 
calculated by 2-tailed t-test). Scale bars: 50μm d. RT-qPCR quantification of ITGα6, TP63, 796 
IVL and TGM1 mRNA levels (relative to 18s expression) (n = 3 independent cultures). e. t-797 
SNE plot of genome-wide transcript expression by keratinocytes placed in suspension for 798 
different times. The t-SNE algorithm takes a set of points in a high-dimensional space and 799 
finds a faithful representation of those points in a lower-dimensional space, typically the 2D 800 
plane. f. Heatmap representing hierarchical clustering of differentially expressed proteins (p < 801 
0.05). g-i. Dot plots correlating expression of significantly differentially expressed peptides (p 802 
< 0.05) that change two fold relative to 0h in at least one of the time points, with their 803 
corresponding differentially expressed transcripts. Pearson correlations (r) are indicated. j. 804 
Histogram of normalised SILAC ratios corresponding to high confidence phosphorylation 805 
sites that differ between 0 and 4h. k. Scatter plot correlating log2 normalized SILAC ratios for 806 
total protein changes (y-axis) with log2 phospho-peptide ratios (x-axis) between 0 and 4h. (b, 807 
c) *p < 0.05; **p < 0.01; ns = non-significant). 808 
 809 
Figure 2. Functional screen identifies candidate phosphatases that regulate commitment. 810 
a. Heatmap showing differential expression at 4, 8 and 12h relative to 0h of phosphatases that 811 
are upregulated at 4h in the microarray dataset. b. Effect of knocking down the 22 812 
phosphatases identified in (a) on clonal growth of keratinocytes. Values plotted are average % 813 
clonal growth in n=3 independent screens with n=3 independent cultures per screen. Green: 814 
siSCR control. Red, blue: phosphatases with statistically significant effects on colony 815 
formation are shown (red: increase; blue: decrease). Grey: no statistically significant effect. c, 816 
d. Effect of knockdowns on clonal growth after 0h, 4h, 8h or 12h in suspension. (c) 817 
Representative dishes. (d) Quantitation of mean % clonal growth ± SD (n=3 independent 818 
samples). P-values generated by unpaired T-test. e, f. RT-qPCR quantification of TP63 (e) 819 
and TGM1 (f) mRNA levels (relative to 18s expression) in the same conditions as in (c). n=3 820 
independent transfections. g. Epidermal reconstitution assay following knockdown of 821 
DUSP6, PTPN1, PPP3CA or PTPN13. n=2 independent transfections. Top row shows 822 
representative H&E images. Epidermal thickness was quantified in multiple fields from 8 823 
sections per replicate ± SD relative to scrambled control (siSCR). Middle row shows staining 824 
for TP63 (pink) with DAPI nuclear counterstain (blue). % DAPI labelled nuclei that were 825 
TP63+ was quantified in n=2-3 fields per replicate. Bottom row shows staining for Ki67 826 
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(brown) with haematoxylin counterstain (blue). % Ki67+ nuclei was quantified in n=3-6 827 
fields per replicate. Error bars represent mean ± s.d. p-values were calculated using one-way 828 
ANOVA with Dunnett's multiple comparisons test (*p < 0.05; **p < 0.01; ****p < 0.0005; 829 
****p < 0.0001; ns = non-significant). 830 
 831 
Figure 3. Pro-commitment phosphatases regulate MAPK signalling and AP1 832 
transcription factors. a. Gene Ontology (GO) term enrichment analysis of ranked peptides 833 
dephosphorylated at 4h. b. Venn diagram showing intersection of signalling pathways 834 
regulated at 4h. c. Top 15 dephosphorylated peptide sites at 4h, showing ratio between change 835 
in phospho-peptides and change in total protein. Highlighted in orange are the MAPK sites. d, 836 
e. Representative western blot (d) and quantification (d) showing phospho-ERK1/2 and total 837 
ERK1/2 in cells harvested after 0, 4, 8 and 12h in suspension. Cyclophilin B: loading control.  838 
f. Heatmap represents mRNA expression (relative to 18s RNA) of AP1 transcription factor 839 
superfamily members during suspension-induced differentiation post-phosphatase knockdown 840 
(n=3; values plotted are means of 3 independent transfections). See Table Supplementary 6 841 
for p-values generated by 2-way ANOVA. g-h. Representative western blot, with 842 
quantitation, of phospho-ERK1/2 and total ERK1/2 in suspended cells following DUSP10 843 
knockdown. siSCR and loading controls are shown. i. Heatmap showing mRNA expression 844 
(relative to 18s mRNA) of JUN, FOS and MAF family members after DUSP6 and DUSP10 845 
knockdown (values plotted are means of 3 independent transfections normalised against 846 
scrambled control; see Table Supplementary 7 for p-values generated by 2-way ANOVA). j. 847 
Clonal growth (representative dishes and quantification) following doxycycline-induced over-848 
expression of DUSP10, DUSP6 and mutant DUSP6
C293S 
in primary keratinocytes (n=3 849 
independent cultures). p-values were calculated using one-way ANOVA with Dunn's multiple 850 
comparisons test (*p < 0.05; ns = non-significant).  851 
 852 
Figure 4. An autoregulatory network of phosphatases controls commitment. a. Colours 853 
represent log2 fold-change in phosphatase mRNA expression relative to 0h (values plotted are 854 
means of 3 independent experiments normalised against siSCR control). b. Experimental 855 
observations that are encoded as constraints on the Boolean network trajectories. We defined 856 
3 experimental constraints (gene expression changes during suspension-induced 857 
differentiation in the absence of pharmacological inhibitors, as well as under TSA and PKCi 858 
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treatments). Each constraint encodes discrete gene expression states at the indicated time 859 
steps. For cells in the absence of drugs we imposed a switching scheme, whereby the system 860 
must change the representative network in order to achieve the expression 861 
constraints.  Yellow boxes indicate the network that represents the system at that step; blank 862 
boxes for a given step (column) indicate that we did not impose a specific network, so the 863 
system can remain in the current network or switch forwards. Active means the gene is 864 
considered to be ‘on’ at that step, inactive means to be ‘off’ at that step. The discretisation is 865 
available in Supplementary Table 9. c. Networks able to satisfy the model constraints of the 866 
Boolean formalism in (b) are depicted. Solid lines show interactions already calculated in (a), 867 
while dashed lines are possible interactions inferred from Fig.4 – Figure Supplement 7. See 868 
also Supplementary Tables 8 and 9. d. Heatmap represents mRNA expression (relative to 18s 869 
mRNA) of individual phosphatases in cells treated in suspension for 12h with PKCi or TSA 870 
(values plotted are the means of 3 independent experiments normalised against vehicle-treated 871 
control). e, f. Representation of commitment as possible two saddle-node bifurcations in a 872 
direction xi of the state space for control cells or cells treated with PKCi or TSA. In the control 873 
both stem and differentiated cell states are stable (attractors), while commitment is an 874 
unstable state. Since the system is able to reach the expression constraint for PKCi at 12h, we 875 
hypothesise that on PKCi treatment, the only stable state is the stem state. On TSA treatment 876 
there is a mandatory switch from the 0h network but the 12h network cannot be reached at 877 
any time point; we therefore hypothesise that commitment becomes a stable state while the 878 
stem and differentiated cell states are unstable. g. 3D-volume rendered confocal images of 879 
wholemounts of human epidermis labelled with antibodies against commitment phosphatases 880 
or ITGβ1 (green) and counterstained with DAPI (blue). The distribution of each phosphatase 881 
relative to ITGβ1 is also shown graphically. h. 3D-volume rendered confocal images of 882 
primary keratinocytes cultured on PDMS topographic substrates and labelled with antibodies 883 
to DUSP10 and DUSP6. Scale bars: 100 μm. 884 
 885 
 886 
Figure Supplement legends 887 
 888 
Fig.1 - Figure Supplement 1. Clonal growth, genomic and proteomic analysis of 889 
suspension-induced terminal differentiation a. Keratinocytes harvested after 0, 1, 2, 4, 6, 8, 890 
10, 12 or 24h in suspension in methylcellulose were seeded at 100, 500 or 1000 cells in 10 891 
29 
 
cm
2
 culture dish on mitotically inactivated J2 3T3 feeders and cultured for 12 days. Following 892 
staining, colonies were counted using ImageJ (n=2 independent experiments with 3 replicate 893 
dishes per experiment; p-value calculated by two tailed t-test). b. RT-qPCR quantification of 894 
IVL and TGM1 mRNA levels at different times in suspension (n=3 independent cultures; p-895 
value calculated by two tailed t-test). c. RT-qPCR quantification of DLL1, Ki67 and Lrig1 896 
mRNA levels at different times in suspension (n=3 independent cultures; p-value calculated 897 
by one-way ANOVA). d. Hierarchical clustering of significantly expressed transcripts at 0h, 898 
4h, 8h and 12h in suspension (each time point represents the mean value of n=3 independent 899 
experiments).  e. GO analysis of differentially expressed genes upregulated at 4, 8 and 12h 900 
relative to 0h. The bar plots represent –log10 of p-values of the identified GO terms. f. 901 
Schematic of SILAC-Mass Spectrometry labelling protocol. g. GO analysis of proteins ranked 902 
in the order of their expression level (fold increase relative to 0h) at 4, 8 and 12h. GO terms 903 
were fetched for individual proteins rather than for clusters of proteins. Bar plots represent –904 
log10 of the p-values of the identified GO terms. a-c. Error bars represent s.d. * p < 0.05; ** p 905 
< 0.01; *** p < 0.005 ; ns = non-significant. 906 
 907 
Fig.2 - Figure Supplement 2. Expression in published datasets of the protein 908 
phosphatases identified by suspension-induced differentiation. a. Heatmap showing 909 
mRNA expression of candidate phosphatases during calcium-induced stratification of primary 910 
human keratinocytes (GSE38628). b. Heatmap showing mRNA expression of candidate 911 
phosphatases during ex vivo human epidermal reconstitution (GSE52651). 912 
 913 
Fig.2 - Figure Supplement 3. Effects of phosphatase knockdown on keratinocyte growth 914 
and differentiation. a. Effect of phosphatase knockdown on colony formation. Values 915 
plotted are average % colony formation in three independent screens with three replicate 916 
dishes per screen. p-values were generated using a two tailed t-test. b. Following siRNA 917 
transfection keratinocytes were seeded in collagen-coated 96 well format dishes and cultured 918 
in KSFM medium for three days. 24h post transfection the culture dishes were moved into an 919 
Incucyte microscope and scanned every hour for the next 48 hours to evaluate cell growth and 920 
proliferation. Each data point is the average of 3 replicate screens with 8 independent well 921 
scans per condition per screen. Values at each time point were normalized to the respective 0h 922 
time point or the first scan point. A cumulative plot is shown with the relative frequency (%) 923 
of cell doublings. c. RT-qPCR quantification of phosphatases mRNA levels relative to 18s 924 
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RNA as a function of time in suspension, showing efficiency of the different knockdowns in 925 
the starting populations. p-values were generated by the unpaired T-test. d. Kinetics of change 926 
in the total area occupied by colonies formed by cells recovered from suspension. (n=3 927 
independent samples). p-values generated by unpaired T-test. e. Growth rate of human 928 
keratinocytes after phosphatase knockdown, calculated by fitting the data in (b) to an 929 
exponential growth curve and averaging the rates. p-values generated by one-way ANOVA f. 930 
Sections of reconstituted epidermis from the experiments shown in Fig.2g labelled with 931 
antibodies to ITGβ1 and IVL, with DAPI as nuclear counterstain. Merge and individual 932 
channel images are depicted. Scale bar: 50 μm. g. Quantification of the experiments shown in 933 
Fig.2g, showing the number of TP63+ (top panel) or Ki67+ cells (bottom panel) per μm of 934 
basement membrane. DAPI labelled nuclei that were TP63+ were quantified in n=2-3 fields 935 
per replicate. % Ki67+ nuclei were quantified in n=3-6 fields per replicate. Error bars 936 
represent mean ± s.d. p-values were calculated using one-way ANOVA. a,c,d,g. Error bars 937 
represent s.d. *p < 0.05; **p < 0.01; ***p < 0.0005; ****p < 0.0001; ns = non-significant. 938 
 939 
Fig.2 - Figure Supplement 4: Effect of shRNA-mediated knockdown of the phosphatases 940 
on epidermal reconstitution. a. RT-qPCR quantification of phosphatase mRNA levels 941 
relative to 18s RNA upon knockdown by lentiviral-mediated shRNA one week after infection 942 
and selection. p-values were generated by one-way ANOVA. b. Epidermal reconstitution 943 
following knockdown of DUSP6, PPTC7, PTPN1, PPP3CA or PTPN13. n=2 independent 944 
infections. Representative H&E images. c. Epidermal thickness was quantified in 8 non-945 
consecutive sections per biological replicate as explained in Fig2. – Figure Supplement 5 and 946 
normalised to shSCR values. p-values were generated by one-way ANOVA. d. 947 
Representative images of epidermis reconstituted by keratinocytes expressing shSCR or 948 
sh1DUSP6 co-stained for TP63 (yellow) and Ki67 (pink) with DAPI nuclear counterstain 949 
(blue). White asterisk shows a TP63+ Ki67- cell. e. % Ki67 labelled nuclei that were also 950 
TP63+ was quantified in n=5 fields per replicate. p-values generated by one-way ANOVA 951 
were >0.05. f. Representative images of epidermis reconstituted by keratinocytes expressing 952 
shSCR or sh1DUSP6 co-stained for TP63 (yellow) and IVL (pink) with DAPI nuclear 953 
counterstain (blue). White asterisk shows a suprabasal cell co-stained for IVL and TP63. a, c, 954 
e. Error bars represent s.d. *p < 0.05; **p < 0.01; ***p < 0.0005; ****p < 0.0001; ns = non-955 
significant 956 
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 957 
Fig.2 - Figure Supplement 5: Workflow for automated quantification of the epidermal 958 
thickness. Sketch representing the automated pathway to extract epidermis thickness from 959 
tissue sections. The python script was divided into three steps. 1) Detection of tissue sections 960 
by processing from “.ndpi” files. With intensity clustering, the background was suppressed 961 
and tissue sections were localised on the slide. Each section was extracted with the highest 962 
resolution and split into 4 vignettes. 2) The epidermis was isolated using information from 963 
H&E staining in each vignette. An automatic thresholding was applied to select only the 964 
epidermis. Potential artefacts that were small in size were suppressed by thresholding on each 965 
object’s size. 3) Epidermal area was measured by pixel counting. To measure epidermal 966 
thickness, area was divided by a 1-pixel wide reduced-topology. 967 
 968 
Fig.3 - Figure Supplement 6. Effects of DUSP10 knockdown and DUSP6 and DUSP10 969 
over-expression. a, b. Western blot (a) and RT-qPCR measurements (b) of DUSP10 970 
knockdown by SMART pool siRNA. p-values were generated by one-tail t-test. c, d. Western 971 
blot of phospho-p38 and total p38 in suspended cells following DUSP10 knockdown. siSCR, 972 
cyclophilin B loading control and quantitation are shown. e. RT-qPCR quantification of 973 
doxycycline-induced over-expression of DUSP6, mutant DUSP6
C293S
 and DUSP10 relative to 974 
18s mRNA. Cells were treated with 1µg/ml doxycycline for 24h. p-values were generated by 975 
a one-tail t-test. f. RT-qPCR quantification of Cumate-induced over-expression of DUSP6 976 
and mutant DUSP6
C293S
 relative to 18s mRNA. p-values were generated by one-way 977 
ANOVA. g. Representative dishes showing effects of overexpressing wild type and mutant 978 
DUSP6 on clonal growth (representative of n=3 dishes). b, e, f. Error bars represent s.d. *p < 979 
0.05; ***p < 0.0005; ****p < 0.0001; ns = non-significant. 980 
 981 
Fig.4 - Figure Supplement 7. Simulated Boolean networks. a. Single ABN with all 982 
possible interactions among the 6 commitment phosphatases. b. RE:SIN representation of the 983 
same networks as in Fig.4a. c. RE:SIN representation of the networks as in b (solid lines) and 984 
additional possible interactions (dashed lines) inferred from Fig.4- figure Supplement 8d, e. 985 
 986 
Fig.4 – Figure Supplement 8. Effects on phosphatase expression of knockdowns and 987 
treatment with TSA or PKCi. a. Heatmaps showing the effect of knocking down individual 988 
phosphatases on mRNA levels of other phosphatases with time in suspension (0h, 4h, 8h, 989 
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12h). RT-qPCR is relative to 18s mRNA (n=3 independent transfections; see Supplementary 990 
Table 9 for p-values generated by two-way ANOVA with Dunnett's multiple comparisons 991 
test). b. Effects of TSA and PKCi on clonogenicity of keratinocytes recovered following 992 
suspension in methylcellulose for 12h. Representative dishes of n=3. c. mRNA levels of IVL, 993 
TGM, ITGα6, and TP63 in cells held in suspension for 12h. Cells were treated with TSA, 994 
PKCi or DMSO (vehicle control) (n = 3 independent treated cultures with two technical 995 
replicates each). p-values for the comparisons were generated by one-way ANOVA. d. 996 
Western blots showing phosphatase levels in primary keratinocytes upon knockdown of 997 
scrambled control (siSCR), DUSP6, PPTC7, PTPN1, PTPN13 or PPP3CA and suspension for 998 
0, 4, 8 or 12h. Cyclophilin B: loading control. e. RT qPCR quantification of phosphatase 999 
mRNA levels (relative to 18s mRNA) following doxycycline-induced over-expression of 1000 
DUSP6, mutant DUSP6
C293S
 and DUSP10. Cells were treated with 1µg/ml doxycycline for 1001 
8h, 24h or 48h (n=3 independent cultures; see Supplement Table 10 for p-values generated by 1002 
two-way ANOVA with Dunnett's multiple comparisons test).  1003 
 1004 
Fig.4 - Figure Supplement 9. DUSP6 and DUSP10 distribution in human epidermal 1005 
wholemounts. a, b. 3D-volume rendered confocal images of human epidermal wholemounts 1006 
labelled with antibodies against DUSP6 (red, a; green, b) and ITG6 (green, a) or DUSP10 1007 
(red, b). Wholemounts were counterstained with DAPI (blue).  1008 
 1009 
Fig.3 – Figure Supplement 10. Uncropped versions of the western blots presented in Fig.3d, 1010 
g and Fig.3 – Figure Supplement c. 1011 
 1012 
 1013 
Table Supplements Legends 1014 
Fig.1 - Table Supplement 1: Log2 fold change of normalized gene expression for all 1015 
pairwise comparisons of mRNA levels during suspension-induced terminal differentiation. 1016 
For each condition the mean of n=3 independent replicates was used and the pairwise fold 1017 
change comparison is between the means of both samples. 1018 
Fig.1 - Table Supplement 2: Proteomics data for all pairwise comparisons of protein levels 1019 
at 4h, 8h and 12h in suspension relative to the 0h control. For each condition the mean of n=3 1020 
independent replicates was used and the pairwise fold change comparison is between the 1021 
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means of both samples. 1022 
Fig.1 - Table Supplement 3: Phosphoproteomics data for pairwise comparisons at 4h and 8h 1023 
in suspension relative to the 0h control.  1024 
Fig.2 - Table Supplement 4: p-values generated for RT qPCR of TP63 and TGM1 for each 1025 
conditional time course relative to control time course (siSCR) by 2-way ANOVA with 1026 
Dunnett's multiple comparisons test (related to Fig. 2f, g). 1027 
Fig.3 - Table Supplement 5: Log2 ratio of phosphopeptides over total proteins at 4h. 1028 
Fig.3 - Table Supplement 6: Effect of phosphatase knockdown on AP1 transcription factor 1029 
expression. p-values generated for each conditional time course relative to control time course 1030 
(SCR) by 2-way ANOVA multiple comparisons (for AP1 superfamily factors). p-values 1031 
generated for RT qPCR of AP1 factors for each conditional time course relative to control 1032 
time course (siSCR) by 2-way ANOVA with Dunnett's multiple comparisons test. 1033 
Fig.3 - Table Supplement 7: Effect of DUSP6 and DUSP10 knockdown on AP1 1034 
transcription factor expression. p-values generated for RT qPCR of AP1 factors relative to 1035 
control cells (siSCR) by 2-way ANOVA.  1036 
Fig.4 - Table Supplement 8: Boolean expression patterns and phosphatases interactions used 1037 
to generate Fig. 4c, d. 1038 
Fig.4 - Table Supplement 9: p-values generated for RT-qPCR of phosphatases for each 1039 
conditional time course relative to control time course (siSCR) by 2-way ANOVA with 1040 
Dunnett's multiple comparisons test.  1041 
Fig.4 - Table Supplement 10: One-way non-parametric ANOVA (Friedman test) with 1042 
Dunn's multiple comparisons test for the effect of overexpressing DUSP6 and DUSP10 on 1043 
mRNA levels of the pro-commitment phosphatases, determined by RT-qPCR.  1044 
Table Supplement 11: siRNA library for phosphatase knockdown.  1045 
Table Supplement 12: shRNA library for phosphatase knockdown. 1046 
Table Supplement 13: List of qPCR primers. 1047 
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